Brain Natriuretic Peptide (BNP) produced by the human chorioamnion may mediate pregnancy myometrial quiescence

Reproductive Sciences

Volumn 16, Issue 1, 2009, Pages 32-42

  Carvajal, Jorge A ^a   Delpiano, Ana M ^a   Cuello, Mauricio A ^a   Poblete, Jose A ^a   Casanello, Paola C ^a   Sobrevia, Luis A ^a   Weiner, Carl P ^b  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^b UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

Amnion; Brain natriuretic peptide; Chorion; Myometrial quiescence

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; NATRIURETIC PEPTIDE TYPE C; OXYTOCIN;

ADULT; ARTICLE; CELL CULTURE; CESAREAN SECTION; CONTROLLED STUDY; FEMALE; FETUS MEMBRANE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; PREGNANCY; PREMATURE LABOR; PREMATURITY; PRIORITY JOURNAL; UTERUS CONTRACTION;

ADULT; BIOPSY; CHORIOALLANTOIC MEMBRANE; FEMALE; HUMANS; LABOR, OBSTETRIC; MYOMETRIUM; NATRIURETIC PEPTIDE, BRAIN; PREGNANCY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; UTERINE CONTRACTION; YOUNG ADULT;

EID: 58249121615     PISSN: 19337191     EISSN: 19337205     Source Type: Journal    
DOI: 10.1177/1933719108324137     Document Type: Article

References (65)

1. Carvajal JA, Weiner CP Mechanisms Underlying Myometrial Quiescence During Pregnancy. Fetal Matern Med Rev. 2003 ; 14: 209-237.
2. Smith R. Parturition. N Engl J Med. 2007 ; 356: 271-283.
3. Lopez Bernal A. The regulation of uterine relaxation. Semin Cell Dev Biol. 2007 ; 18: 340-347.
4. Carvajal JA, Buhimschi IA, Thompson LP, Aguan K., Weiner CP Chorion releases a factor that inhibits oxytocin-stimulated myometrial contractility in the pregnant guinea pig. Hum Reprod. 2001 ; 16: 638-643.
5. Carvajal JA, Vidal RJ, Cuello MA, Poblete JA, Weiner CP Mechanisms of paracrine regulation by fetal membranes of human uterine quiescence. J Soc Gynecol Invest. 2006 ; 13: 343-349.
6. Carvajal JA, Thompson LP, Weiner CP Chorion-induced myometrial relaxation is mediated by large-conductance Ca2+-activated K+ channel opening in the guinea pig. Am J Obstet Gynecol. 2003 ; 188: 84-91.
7. Collins PL, Idriss E., Moore JJ Human fetal membranes inhibit spontaneous uterine contractions. J Clin Endocrinol Metab. 1993 ; 77: 1479-1484.
8. Collins PL, Idriss E., Moore JJ Fetal membranes inhibit prostaglandin but not oxytocin-induced uterine contractions. Am J Obstet Gynecol. 1995 ; 172 (4 pt 1). 1216-1223.
9. Collins PL, Moore JJ, Idriss E., Kulp TM Human fetal membranes inhibit calcium L-channel activated uterine contractions. Am J Obstet Gynecol. 1996 ; 175: 1173-1179.
10. Emery SP, Idriss E., Richmonds C., Collins PL Human fetal membranes release a Ca++ channel inhibitor. Am J Obstet Gynecol. 1998 ; 179: 989-993.
11. Carroll EM, Gianopoulos JG, Collins PL Abnormality of calcium channel inhibitor released from fetal membranes in preterm labor. Am J Obstet Gynecol. 2001 ; 184: 356-362.
12. Buxton IL Regulation of uterine function: a biochemical conundrum in the regulation of smooth muscle relaxation. Mol Pharmacol. 2004 ; 65: 1051-1059.
13. Price SA, Bernal AL Uterine quiescence: the role of cyclic AMP. Exp Physiol. 2001 ; 86: 265-272.
14. Yuan W., Lopez Bernal A. Cyclic AMP signaling pathways in the regulation of uterine relaxation. BMC Pregnancy Childbirth. 2007 ; 7 (suppl 1). S10.
15. Europe-Finner GN, Phaneuf S., Tolkovsky AM, Watson SP, Lopez Bernal A. Down-regulation of G alpha s in human myometrium in term and preterm labor: a mechanism for parturition. J Clin Endocrinol Metab. 1994 ; 79: 1835-1839.
16. Lindeman KS, Forrester DJ, Hirshman CA, Emala CW Myometrial adenylyl cyclase protein decreases on the last day of pregnancy in the rat. Biol Reprod. 2000 ; 62: 1422-1426.
17. Sanborn BM, Yue C., Wang W., Dodge KL G protein signaling pathways in myometrium: affecting the balance between contraction and relaxation. Rev Reprod. 1998 ; 3: 196-205.
18. Arkinstall SJ, Jones CT Influence of pregnancy on G-protein coupling to adenylate cyclase activation in guinea-pig myometrium. J Endocrinol. 1990 ; 127: 15-21.
19. Europe-Finner GN, Phaneuf S., Watson SP, Lopez Bernal A. Identification and expression of G-proteins in human myometrium: up-regulation of G alpha s in pregnancy. Endocrinology. 1993 ; 132: 2484-2490.
20. Europe-Finner GN, Phaneuf S., Cartwright E., Mardon HJ, Lopez Bernal A. Expression of human myometrial G alpha s messenger ribonucleic acid transcript during pregnancy and labour: involvement of alternative splicing pathways. J Mol Endocrinol. 1997 ; 18: 15-25.
21. Gsell S., Eschenhagen T., Kaspareit G., et al. Apparent up-regulation of stimulatory G-protein alpha subunits in the pregnant human myometrium is mimicked by elevated smoothelin expression. Faseb J. 2000 ; 14: 17-26.
22. Price SA, Pochun I., Phaneuf S., Lopez Bernal A. Adenylyl cyclase isoforms in pregnant and non-pregnant human myometrium. J Endocrinol. 2000 ; 164: 21-30.
23. Mhaouty-Kodja S., Bouet-Alard R., Limon-Boulez I., Maltier JP, Legrand C. Molecular diversity of adenylyl cyclases in human and rat myometrium. Correlation with global adenylyl cyclase activity during mid- and term pregnancy. J Biol Chem. 1997 ; 272: 31100-31106.
24. Brodt-Eppley J., Myatt L. Prostaglandin receptors in lower segment myometrium during gestation and labor. Obstet Gynecol. 1999 ; 93: 89-93.
25. Grigsby PL, Sooranna SR, Adu-Amankwa B., et al. Regional expression of prostaglandin E2 and F2alpha receptors in human myometrium, amnion, and choriodecidua with advancing gestation and labor. Biol Reprod. 2006 ; 75: 297-305.
26. Dong YL, Fang L., Kondapaka S., Gangula PR, Wimalawansa SJ, Yallampalli C. Involvement of calcitonin gene-related peptide in the modulation of human myometrial contractility during pregnancy. J Clin Invest. 1999 ; 104: 559-565.
27. Goharkhay N., Lu J., Felix JC, Wing DA Expression of calcitonin gene-related peptide-receptor component protein (CGRP-RCP) in human myometrium in differing physiological states and following misoprostol administration. Am J Perinatol. 2007 ; 24: 497-500.
28. Yallampalli C., Gangula PR, Kondapaka S., Fang L., Wimalawansa S. Regulation of calcitonin gene-related peptide receptors in the rat uterus during pregnancy and labor and by progesterone. Biol Reprod. 1999 ; 61: 1023-1030.
29. Engstrom T., Bratholm P., Vilhardt H., Christensen NJ Effect of pregnancy on rat myometrial beta 2-adrenoceptor mRNA and isoproterenol-induced relaxation of isolated uterine strips. J Endocrinol. 1997 ; 153: 393-399.
30. Gaspar R., Ducza E., Mihalyi A., et al. Pregnancy-induced decrease in the relaxant effect of terbutaline in the late-pregnant rat myometrium: role of G-protein activation and progesterone. Reproduction. 2005 ; 130: 113-122.
31. Litime MH, Pointis G., Breuiller M., Cabrol D., Ferre F. Disappearance of beta-adrenergic response of human myometrial adenylate cyclase at the end of pregnancy. J Clin Endocrinol Metab. 1989 ; 69: 1-6.
32. Zuo J., Lei ZM, Rao CV Human myometrial chorionic gonadotropin/ luteinizing hormone receptors in preterm and term deliveries. J Clin Endocrinol Metab. 1994 ; 79: 907-911.
33. Grammatopoulos DK The role of CRH receptors and their agonists in myometrial contractility and quiescence during pregnancy and labour. Front Biosci. 2007 ; 12: 561-571.
34. Grammatopoulos DK, Hillhouse EW Role of corticotropinreleasing hormone in onset of labour. Lancet. 1999 ; 354: 1546-1549.
35. Challis JRG, Matthews SG, Gibb W., Lye SJ Endocrine and paracrine regulation of birth at term and preterm. Endocr Rev. 2000 ; 21: 514-550.
36. Weiner CP, Knowles RG, Nelson SE, Stegink LD Pregnancy increases guanosine 3,'5'-monophosphate in the myometrium independent of nitric oxide synthesis. Endocrinology. 1994 ; 135: 2473-2478.
37. Buhimschi I., Yallampalli C., Dong YL, Garfield RE Involvement of a nitric oxide-cyclic guanosine monophosphate pathway in control of human uterine contractility during pregnancy. Am J Obstet Gynecol. 1995 ; 172: 1577-1584.
38. Telfer JF, Itoh H., Thomson AJ, et al. Activity and expression of soluble and particulate guanylate cyclases in myometrium from nonpregnant and pregnant women: down-regulation of soluble guanylate cyclase at term. J Clin Endocrinol Metab. 2001 ; 86: 5934-5943.
39. Carvajal JA, Germain AM, Huidobro-Toro JP, Weiner CP Molecular mechanism of cGMP-mediated smooth muscle relaxation. J Cell Physiol. 2000 ; 184: 409-420.
40. Yallampalli C., Izumi H., Byam-Smith M., Garfield RE An L-arginine-nitric oxide-cyclic guanosine monophosphate system exists in the uterus and inhibits contractility during pregnancy. Am J Obstet Gynecol. 1994 ; 170 (1 pt 1). 175-185.
41. Zhou XB, Wang GX, Ruth P., Huneke B., Korth M. BK(Ca) channel activation by membrane-associated cGMP kinase may contribute to uterine quiescence in pregnancy. Am J Physiol Cell Physiol. 2000 ; 279: C1751-1759.
42. Bradley KK, Buxton IL, Barber JE, McGaw T., Bradley ME Nitric oxide relaxes human myometrium by a cGMPindependent mechanism. Am J Physiol. 1998 ; 275 (6 pt 1). C1668 - C1673.
43. Buxton IL, Kaiser RA, Malmquist NA, Tichenor S. NO-induced relaxation of labouring and non-labouring human myometrium is not mediated by cyclic GMP. Br J Pharmacol. 2001 ; 134: 206-214.
44. Cea LB Natriuretic peptide family: new aspects. Curr Med Chem Cardiovasc Hematol Agents. 2005 ; 3: 87-98.
45. Graham CH, Watson JD, Blumenfeld AJ, Pang SC Expression of atrial natriuretic peptide by third-trimester placental cytotrophoblasts in women. Biol Reprod. 1996 ; 54: 834-840.
46. Itoh H., Sagawa N., Hasegawa M., et al. Brain natriuretic peptide is present in the human amniotic fluid and is secreted from amnion cells. J Clin Endocrinol Metab. 1993 ; 76: 907-911.
47. Itoh H., Sagawa N., Hasegawa M., et al. Expression of biologically active receptors for natriuretic peptides in the human uterus during pregnancy. Biochem Biophys Res Commun. 1994 ; 203: 602-607.
48. Carvajal JA, Aguan K., Thompson LP, Buhimschi IA, Weiner CP Natriuretic peptide-induced relaxation of myometrium from the pregnant guinea pig is not mediated by guanylate cyclase activation. J Pharmacol Exp Ther. 2001 ; 297: 181-188.
49. Buhimschi CS, Buhimschi IA, Zhao G., et al. Biomechanical properties of the lower uterine segment above and below the reflection of the urinary bladder flap. Obstet Gynecol. 2007 ; 109: 691-700.
50. Suga S., Nakao K., Hosoda K., et al. Receptor selectivity of natriuretic peptide family, atrial natriuretic peptide, brain natriuretic peptide, and C-type natriuretic peptide. Endocrinology. 1992 ; 130: 229-239.
51. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987 ; 162: 156-159.
52. Lundin-Schiller S., Mitchell MD Prostaglandin production by human chorion laeve cells in response to inflammatory mediators. Placenta. 1991 ; 12: 353-363.
53. Okita JR, Sagawa N., Casey ML, Snyder JM A comparison of human amnion tissue and amnion cells in primary culture by morphological and biochemical criteria. In Vitro. 1983 ; 19: 117-126.
54. Hennan JK, Diamond J. Evidence that spontaneous contractile activity in the rat myometrium is not inhibited by NO-mediated increases in tissue levels of cyclic GMP. Br J Pharmacol. 1998 ; 123: 959-967.
55. Villar IC, Panayiotou CM, Sheraz A., et al. Definitive role for natriuretic peptide receptor-C in mediating the vasorelaxant activity of C-type natriuretic peptide and endothelium-derived hyperpolarising factor. Cardiovasc Res. 2007 ; 74: 515-525.
56. Rose RA, Giles WR Natriuretic peptide C receptor signalling in the heart and vasculature. J Physiol. 2008 ; 586: 353-366.
57. Lev-Sagie A., Bar-Oz B., Salpeter L., Hochner-Celnikier D., Arad I., Nir A. Plasma concentrations of N-terminal Pro-B-Type natriuretic peptide in pregnant women near labor and during early puerperium. Clin Chem. 2005 ; 51: 1909-1910.
58. Bar-Oz B., Lev-Sagie A., Arad I., Salpeter L., Nir A. N-terminal pro-B-type natriuretic peptide concentrations in mothers just before delivery, in cord blood, and in newborns. Clin Chem. 2005 ; 51: 926-927.
59. Itoh H., Sagawa N., Nanno H., Mori T., Mukoyama M., Nakao K. Impaired guanosine 3,'5'-cyclic phosphate production in severe pregnancy-induced hypertension with high plasma levels of atrial and brain natriuretic peptides. Endocr J. 1997 ; 44: 389-393.
60. Lauria MR, Standley CA, Sorokin Y., et al. Brain natriuretic peptide and cyclic guanosine-3,'5' monophosphate in preeclampsia. J Matern Fetal Med. 1996 ; 5: 128-131.
61. Fleming SM, O'Byrne L., Grimes H., Daly KM, Morrison JJ Amino-terminal pro-brain natriuretic peptide in normal and hypertensive pregnancy. Hypertens Pregnancy. 2001 ; 20: 169-175.
62. Resnik JL, Hong C., Resnik R., et al. Evaluation of B-type natriuretic peptide (BNP) levels in normal and preeclamptic women. Am J Obstet Gynecol. 2005 ; 193: 450-454.
63. Kale A., Kale E., Yalinkaya A., Akdeniz N., Canoruc N. The comparison of amino-terminal probrain natriuretic peptide levels in preeclampsia and normotensive pregnancy. J Perinat Med. 2005 ; 33: 121-124.
64. Girsen A., Ala-Kopsala M., Makikallio K., Vuolteenaho O., Rasanen J. Cardiovascular hemodynamics and umbilical artery N-terminal peptide of proB-type natriuretic peptide in human fetuses with growth restriction. Ultrasound Obstet Gynecol. 2007 ; 29: 296-303.
65. Itoh H., Sagawa N., Hasegawa M., et al. Transforming growth factor-beta stimulates, and glucocorticoids and epidermal growth factor inhibit brain natriuretic peptide secretion from cultured human amnion cells. J Clin Endocrinol Metab. 1994 ; 79: 176-182.